OLR1 is closely related to poor prognosis and immune cell infiltration in gastric cancer

Meixia Zhang, Qingzi Fu, Bo Jiang, Zhenzhen Yang, Qiaofeng Chen, Peng Chen, Shiyu ZhangResearch Square 2025 · DOI

TL;DR

This study identifies OLR1 (Oxidized low-density lipoprotein receptor 1) as a significant biomarker for gastric cancer (GC), showing it is markedly upregulated in tumor tissues and serves as an independent predictor of poor patient survival. Furthermore, the researchers established a strong link between high OLR1 expression and increased infiltration of immune cells, particularly macrophages, suggesting OLR1 plays a key role in remodeling the tumor microenvironment.

What Problem Does This Paper Address?

Gastric cancer remains a global health challenge due to its high mortality rate and often late-stage diagnosis. While immunotherapy has emerged as a promising treatment, its effectiveness depends heavily on the "immune landscape" of the tumor—specifically, which immune cells are present and how they interact with cancer cells.

The authors sought to address the lack of reliable prognostic biomarkers that also provide insight into the tumor microenvironment (TME). They focused on OLR1, a receptor typically studied in the context of vascular inflammation and lipid metabolism, to determine if it influences gastric cancer progression and immune cell infiltration.

Methods

The researchers employed a "dry lab to wet lab" validation pipeline:

  • Bioinformatics: They integrated large-scale transcriptomic data from TCGA, GTEx, and GEO databases to compare OLR1 expression in cancerous vs. normal tissues and across different cancer types (pan-cancer analysis).
  • Functional Enrichment: Using Gene Set Enrichment Analysis (GSEA) and KEGG pathway analysis, they identified biological processes associated with OLR1-related differentially expressed genes (DEGs).
  • Immune Profiling: They used single-sample GSEA (ssGSEA) to correlate OLR1 levels with the abundance of 24 types of immune cells.
  • Clinical Validation: To move beyond database mining, they performed quantitative real-time PCR (qPCR) on 20 patient samples and immunohistochemistry (IHC) on a cohort of 80 patients to confirm OLR1 protein and mRNA levels in actual clinical tissues.
  • Predictive Modeling: A nomogram was constructed using multivariate Cox regression to provide a practical tool for predicting 1-, 3-, and 5-year survival probabilities.

Datasets

  • TCGA-STAD: 414 gastric cancer tissues and 36 adjacent non-carcinoma tissues.
  • GTEx: 174 normal gastric tissues (used to increase the control sample size).
  • GEO (Gene Expression Omnibus): Two independent datasets (GSE13911 and GSE54129) were used for external validation of the diagnostic findings.
  • In-house Clinical Cohort: 20 samples for qPCR and 80 samples for IHC from the First Affiliated Hospital of Nanchang University.

Key Insights and Ideas

  • The Metabolic-Cancer Link: OLR1 is primarily known as a receptor for oxidized LDL. Its significant role in gastric cancer suggests a metabolic reprogramming where lipid-related signaling might be driving tumor aggression.
  • Macrophage Magnet: The strongest correlation found was between OLR1 and macrophage infiltration ($r = 0.742$). This suggests that OLR1 might help recruit or polarize macrophages, potentially creating an immunosuppressive environment that allows the tumor to evade the immune system.
  • Independent Prognosticator: Even when accounting for age and cancer stage, OLR1 expression remained an independent risk factor for overall survival. This makes it a "clean" biomarker that adds value beyond standard clinical staging.
  • Microbiome Connection: Interestingly, OLR1-associated genes were enriched in pathways related to Staphylococcus aureus infection, hinting at a possible (though unexplored) link between the gastric microbiome, inflammation, and OLR1 expression.

Key Results

  • Diagnostic Accuracy: OLR1 showed high diagnostic performance with an Area Under the Curve (AUC) of 0.904 in the TCGA dataset and similarly high values (0.823–0.842) in GEO datasets.
  • Survival Impact: Patients in the high-OLR1 expression group had significantly worse overall survival (OS) compared to the low-expression group ($P = 0.024$).
  • Clinical Correlation: High OLR1 levels were significantly associated with more advanced histological grades ($P < 0.001$), deeper tumor invasion (T stage, $P < 0.01$), and more advanced pathological stages ($P < 0.05$).
  • Nomogram Performance: The predictive model (nomogram) achieved a C-index of 0.627, indicating a moderate to good ability to predict long-term patient outcomes.

Limitations and Future Work

The authors acknowledge several areas for further development:

  • Retrospective Nature: The study relies on existing databases and retrospective clinical samples; prospective trials are needed to confirm the nomogram's utility.
  • Mechanistic Gap: While the paper establishes a correlation between OLR1 and immune infiltration, it does not prove causality. The exact molecular pathways by which OLR1 influences macrophages remain a "black box."
  • Single-Center Validation: The clinical validation was performed at a single institution. Multi-center studies with more diverse populations would strengthen the findings.
  • Future Direction: The authors suggest that future research should focus on whether targeting OLR1 (e.g., with inhibitors or antibodies) could enhance the efficacy of existing immunotherapies in gastric cancer.

Summary updated

Abstract

<title>Abstract</title> <bold>Background</bold> : Oxidized low-density lipoprotein receptor 1 (OLR1) in gastric cancer (GC) progression and immune cell infiltration remains unclear. This study aimed to investigate the impact of OLR1 on GC progression and to elucidate its association with immune cell infiltration in GC. <bold>Materials and Methods</bold> : OLR1 expression profiles in GC and paired normal tissues were analyzed using datasets from the TCGA, GTEx, and GEO databases, with validation conducted through quantitative real-time PCR (qPCR) and immunohistochemistry (IHC). Differentially expressed genes (DEGs) associated with OLR1 were identified through gene set enrichment analysis (GSEA) and functional enrichment analysis. We evaluated the role of OLR1 in GC immune cell infiltration. In addition, Cox regression and Kaplan-Meier analyses were conducted on OLR1 for its prognostic significance and correlation with clinical variables. Finally, survival probabilities in GC patients were predicted by nomogram construction. <bold>Results</bold> : OLR1 expression in GC tissues significantly increased relative to that in matched normal samples (P &lt; 0.001), as confirmed by qPCR and IHC (both P &lt; 0.05). There were 268 DEGs associated with <italic>Staphylococcus</italic> <italic>aureus</italic> infection, protein digestion and absorption signaling, and the estrogen signaling pathway. OLR1 expression was positively related to macrophage infiltration (r = 0.742, P &lt; 0.001, as validated by IHC). Additionally, OLR1 expression was strongly related to histological grade (P &lt; 0.001), histological type (P &lt; 0.05), T stage (P &lt; 0.01), pathological stage (P &lt; 0.05), and unfavorable overall survival (OS, P &lt; 0.05). Our established nomogram effectively predicted the 1-, 3-, and 5-year OS probabilities in patients with GC (C-index [95% CI] = 0.627 [0.601–0.652]). <bold>Conclusion</bold> : OLR1 is strongly associated with a dismal prognostic outcome and immune cell infiltration in patients with GC.
BibTeX
@inproceedings{zhang2025olr,
  author = {Meixia Zhang and Qingzi Fu and Bo Jiang and Zhenzhen Yang and Qiaofeng Chen and Peng Chen and Shiyu Zhang},
  title = {{OLR1 is closely related to poor prognosis and immune cell infiltration in gastric cancer}},
  booktitle = {Research Square},
  year = {2025},
  doi = {10.21203/rs.3.rs-6509290/v1},
}
Figure